Increased plasma homocysteine levels in multiple sclerosis

Multiple Sclerosis

Volumn 13, Issue 7, 2007, Pages 945-946

  Sahin, S ^a   Aksungar, F B ^a   Topkaya, A E ^a   Yildiz, Z ^b   Boru, U T ^b   Ayalp, S ^a   Karsidag, S ^a  

^a MALTEPE UNIVERSITY   (Turkey)

^b Dr Lutfi Kirdar Kartal Research and Training Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; IMMUNOASSAY; LETTER; MALE; MULTIPLE SCLEROSIS; REFERENCE VALUE; SEX DIFFERENCE; TURKEY (REPUBLIC); VITAMIN BLOOD LEVEL; BLOOD; HYPERHOMOCYSTEINEMIA; MIDDLE AGED;

ADULT; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 35848958559     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458506075503     Document Type: Letter

References (10)

1. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-83.
2. Baig Sm, Qureshi G. Homocysteine and vitamin B12 in multiple sclerosis. Biogen Amines 1995; 11: 479-85.
3. Ashtari F, Salehi Abari Sh, Shaygan Nejad V. Serum homocysteine level in patients with multiple sclerosis. JRMS 2005; 10: 302-304.
4. Ramsaransing GS, Fokkema MR, Teelken A, Arutjunyan AV, Koch M, De Keyser J. Plasma homocysteine levels in multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77(2): 189-92.
5. Vrethem M, Mattsson E, Hebelka H, Leerbeck K, Osterberg A, Landtblom AM, et al. Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methyl-malonic acid. Mult Scler 2003; 9: 239-45.
6. Turk Born U, Alp R, Sur H, Gul L. Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey. Neuroepidemiology 2006; 27: 17-21.
7. Nilsson-Ehle H. Age-related changes in cobalamin (vitamin B12) handling. Implications therapy. Drugs Aging 1998; 12: 277-92.
8. Krumdieck CL, Prince CW. Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr 2000; 130: 365-68.
9. Jakubowski H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr 2000; 130: 377-81.
10. Au-Yeung KKW, Woo CWH, Sung FL, Yip JCW, Siow YL, OK. Hyperhomocysteinemia activates nuclear factor-kappa B in endothelial cells via oxidative stress. Circ Res 2004; 94: 28-36.